Advertisement
Screener

Kronos Bio, Inc. Operating Cash Flow

Kronos Bio, Inc. Operating Cash Flow

Kronos Bio, Inc. reported Operating Cash Flow of -$12.84 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-05-08

  • Kronos Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$12.84M.
  • Kronos Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$12.84M.
  • Kronos Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$12.37M.
  • Kronos Bio, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$16.33M.
  • Kronos Bio, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$65.44M.
  • Kronos Bio, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$78.58M.
  • Kronos Bio, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$90.93M.
  • Kronos Bio, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$117.92M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2025-03-31-$12.84M
10-Q · filed 2025-05-08
-$25.68M
derived: sum of 2 quarters · filed 2025-05-08
-$38.05M
derived: sum of 3 quarters · filed 2025-05-08
-$54.38M
derived: sum of 4 quarters · filed 2025-05-08
2024-12-31-$12.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
-$25.21M
derived: sum of 2 quarters · filed 2025-03-18
-$41.54M
derived: sum of 3 quarters · filed 2025-03-18
-$65.44M
10-K · filed 2025-03-18
2024-09-30-$12.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
-$28.70M
derived: sum of 2 quarters · filed 2024-11-13
-$52.60M
10-Q · filed 2024-11-13
-$77.62M
derived: sum of 4 quarters · filed 2025-05-08
2024-06-30-$16.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$40.23M
10-Q · filed 2024-08-08
-$65.25M
derived: sum of 3 quarters · filed 2025-05-08
-$87.84M
derived: sum of 4 quarters · filed 2025-05-08
2024-03-31-$23.90M
10-Q · filed 2025-05-08
-$48.92M
derived: sum of 2 quarters · filed 2025-05-08
-$71.51M
derived: sum of 3 quarters · filed 2025-05-08
-$96.53M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31-$25.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
-$47.61M
derived: sum of 2 quarters · filed 2025-03-18
-$72.64M
derived: sum of 3 quarters · filed 2025-03-18
-$78.58M
10-K · filed 2025-03-18
2023-09-30-$22.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
-$47.61M
derived: sum of 2 quarters · filed 2024-11-13
-$53.56M
10-Q · filed 2024-11-13
-$76.09M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30-$25.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$30.97M
10-Q · filed 2024-08-08
-$53.50M
derived: sum of 3 quarters · filed 2024-08-08
-$75.89M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$5.95M
10-Q · filed 2024-05-09
-$28.48M
derived: sum of 2 quarters · filed 2024-05-09
-$50.87M
derived: sum of 3 quarters · filed 2024-05-09
-$73.39M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$22.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
-$44.92M
derived: sum of 2 quarters · filed 2024-03-21
-$67.44M
derived: sum of 3 quarters · filed 2024-03-21
-$90.93M
10-K · filed 2024-03-21
2022-09-30-$22.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
-$44.91M
derived: sum of 2 quarters · filed 2023-11-13
-$68.40M
10-Q · filed 2023-11-13
-$126.92M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$22.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$46.00M
10-Q · filed 2023-08-08
-$104.53M
derived: sum of 3 quarters · filed 2023-08-08
-$124.67M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$23.48M
10-Q · filed 2023-05-10
-$82.01M
derived: sum of 2 quarters · filed 2023-05-10
-$102.15M
derived: sum of 3 quarters · filed 2023-05-10
-$122.41M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31-$58.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
-$78.66M
derived: sum of 2 quarters · filed 2023-03-15
-$98.93M
derived: sum of 3 quarters · filed 2023-03-15
-$117.92M
10-K · filed 2023-03-15
2021-09-30-$20.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$40.40M
derived: sum of 2 quarters · filed 2022-11-08
-$59.40M
10-Q · filed 2022-11-08
-$75.03M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$20.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$39.26M
10-Q · filed 2022-08-04
-$54.89M
derived: sum of 3 quarters · filed 2022-08-04
-$65.18M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31-$19.00M
10-Q · filed 2022-05-04
-$34.63M
derived: sum of 2 quarters · filed 2022-05-04
-$44.91M
derived: sum of 3 quarters · filed 2022-05-04
-$49.84M
derived: sum of 4 quarters · filed 2022-05-04
2020-12-31-$15.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$25.92M
derived: sum of 2 quarters · filed 2022-02-24
-$30.85M
derived: sum of 3 quarters · filed 2022-02-24
-$37.91M
10-K · filed 2022-02-24
2020-09-30-$10.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$15.22M
derived: sum of 2 quarters · filed 2021-11-09
-$22.28M
10-Q · filed 2021-11-09
-$27.22M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$4.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$12.00M
10-Q · filed 2021-08-12
-$16.94M
derived: sum of 3 quarters · filed 2022-02-24
2020-03-31-$7.07M
10-Q · filed 2021-05-11
-$12.01M
derived: sum of 2 quarters · filed 2022-02-24
2019-12-31-$4.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$15.08M
10-K · filed 2022-02-24
2019-09-30-$10.14M
10-Q · filed 2020-11-18
2018-12-31-$6.44M
10-K · filed 2021-03-23